12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Deals

Genetrix, Sygnis Pharma deal

Sygnis shareholders approved the company's acquisition of Genetrix's X-Pol Biotech S.L. subsidiary. X-Pol will become a wholly-owned subsidiary of Sygnis, which will develop and market X-Pol's DNA sequencing technologies and products. Existing...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >